Overview of the Use of Doxycycline as Prophylaxis for Sexually Transmitted Infections
An Integrative Review
DOI:
https://doi.org/10.21727/rpu.v16i1.4873Abstract
The use of pre-exposure prophylaxis for the Human Immunodeficiency Virus (PrEP-HIV) has been linked to an increase in other sexually transmitted infections due to its effectiveness in reducing HIV transmission and, consequently, adherence to condom use. Therefore, there is a need for a study to analyze the evidence of the use of Doxycycline against bacterial STIs, in order to recommend post-exposure prophylaxis as a public health policy. An integrative literature review was conducted with data from "Pubmed," "Scielo," "Virtual Health Library," and "Cochrane Trials" from the past 10 years, using the descriptors "Sexually Transmitted Disease," "Doxycycline," and "Primary Disease Prevention." In the analyzed studies, it was proven that the use of doxycycline within 24 hours after unprotected sexual activity resulted in a lower occurrence of STIs compared to those who did not perform prophylaxis. It is concluded that prophylaxis with doxycycline proved to be relevant in containing the increase in the number of cases among individuals who engage in risky behavior. However, the importance of epidemiological surveillance for the emergence of strains resistant to the proposed regimen is emphasized.
Keywords: Sexually Transmitted Disease; Doxycycline; Primary Disease Prevention
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Matheus Alvarenga, Ana Clara Farias de Negri, Maria Clara Tardeli de Almeida, Nicolly da Fonseca Andrade, Mayra da Silva Freire, Vinicius Martins de Menezes

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which allows sharing the work with acknowledgement of authorship and initial publication through this journal.
This license lets others distribute, remix, adapt and create upon your work, even commercially, as long as they credit you for the original creation. It is the most flexible license of all available. It is recommended for maximizing the dissemination and use of the licensed materials.
Authors are permitted to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. by posting it to an institutional repository or as a chapter in a book), with acknowledgement of the work's authorship and initial publication in this journal.
See the full legal text of the license at: https://creativecommons.org/licenses/by/4.0/









